Giảm mật độ chất vận chuyển Dopamine ở dải não trong những người ngừng sử dụng Methamphetamine và Methcathinone: Bằng chứng từ các nghiên cứu chụp PET với [11C]WIN-35,428

10.1016/0028-3908(81)90053-8

Brill, 1969, The rise and fall of a methamphetamine epidemic., Semin Psychiatry, 1, 179

Calkins, 1995, Methcathinone: the next illicit stimulant epidemic?, J Psychoact Drugs, 27, 277, 10.1080/02791072.1995.10472472

10.1002/syn.890060211

Cerruti, 1994, Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration., Mol Brain Res, 22, 1, 10.1016/0169-328X(94)90040-X

Chappell W Mordenti J (1991) Extrapolation of toxicological and pharmacological data from animals to humans. in Advances in drug research, ed Testa B (Academic, San Diego), pp 1–116.

10.1002/jlcr.2580330209

Emerson, 1993, Methcathinone: A russian designer amphetamine infiltrates the rural midwest., Ann Emerg Med, 22, 129, 10.1016/S0196-0644(05)80419-6

Evans, 1991, MRI–PET correlation in three dimensions using a volume-of-interest (VOI) atlas., J Cereb Blood Flow Metab, 11, A69, 10.1038/jcbfm.1991.40

10.1002/ana.410400609

10.1016/S0014-2999(97)01152-7

10.1002/ana.410340331

Gibb JW Hanson GR Johnson M (1994) Neurochemical mechanisms of toxicity. in Amphetamine and its analogs, eds Cho AK Segal DS (Academic, San Diego), pp 269–295.

10.1002/ana.410400610

10.1001/jama.1993.03500190050033

Gygi, 1996, Methcathinone: an initial study of its effects on monoaminergic systems., J Pharmacol Exp Ther, 276, 1066

Hirata, 1997, p53-Knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies., J Neurochem, 69, 780, 10.1046/j.1471-4159.1997.69020780.x

Hornykiewicz, 1966, Dopamine (3-hydroxytyramine) and brain function., Pharmacol Rev, 18, 925

Hotchkiss, 1980, Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain., J Pharmacol Exp Ther, 214, 257

Kall K (1997) Amphetamine abuse in Sweden. in Amphetamine misuse, ed Klee H (Harwood Academic, The Netherlands), pp 215–233.

10.1002/syn.890090107

10.1002/syn.890090304

Kish, 1988, Uneven pattern of dopamine loss in the striatum of patients with Parkinson’s disease., N Engl J Med, 318, 867, 10.1056/NEJM198804073181402

Koff, 1994, Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding., J Pharmacol Exp Ther, 268, 277

Kozel N (1997) Epidemiologic trends in drug abuse, Vol 1. National Institute on Drug Abuse, NIH Publication No.97–4204.SS.

10.1016/0006-8993(80)91341-4

Lukas SE (1997) Proceedings of the national consensus meeting on the use, abuse and sequelae of abuse of methamphetamine with implications for prevention, treatment and research. DHHS Publication SMA. 96–8013. (USDHHS, Rockville, MD).

Madras, 1989, Cocaine receptors labeled by [3H]-b-carbomethoxy-3-b-(4-fluorophenyl)-tropan., Mol Pharmacol, 36, 518

Malison, 1998, Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I]β-CIT SPECT., Am J Psychiatry, 155, 832

Melega, 1993, FDOPA-PET studies show neurotoxic effects of low-dose amphetamine in monkeys., Soc Neurosci Abstr, 19, 822

Miller M Hughes A (1994) Epidemiology of amphetamine abuse in the United States. Use and abuse of amphetamines in Japan. in Amphetamine and its analogs, eds Cho AK Segal DS (Academic, San Diego), pp 439–457.

Mordenti J Chappell W (1989) The use of interspecies scaling in toxicokinetics. in Toxicokinetics in new drug development, eds Yacobi A Kelly J Batra V (Pergamon, New York), pp 42–96.

10.1016/0006-8993(82)90198-6

10.1016/0006-8993(84)91221-6

Seiden LS Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs. in Psychopharmacology—the third generation of progress, ed Meltzer HY (Raven, New York), pp 359–366.

10.1016/0376-8716(76)90030-2

10.1126/science.2563176

10.1016/0006-8993(96)00995-X

Sparago, 1996, Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse., J Pharmacol Exp Ther, 279, 1043

Steranka, 1980, Long-term effects of continuous exposure to amphetamine in brain dopamine concentration and synaptosomal uptake in mice., Eur J Pharmacol, 65, 433, 10.1016/0014-2999(80)90351-9

Suwaki H Fukui S Konuma K (1997) Methamphetamine abuse in Japan: its 45 year history and the current situation. in Amphetamine misuse, ed Klee H (Harwood Academic, The Netherlands), pp 199–214.

10.1111/j.1600-0404.1988.tb05894.x

Tella, 1997, Differential regulation of dopamine transporter after chronic self administration of buproprion and nomifensine., J Pharmacol Exp Ther, 281, 508

Tolliver, 1995, Methcathinone: a new amphetamine-like drug of abuse., Natl Inst Drug Abuse Res Monogr Ser, 153, 406

U.S Department of Justice, Drug Enforcement Administration (1994) Methcathinone (CAT). Drug intelligence bulletin. Washington, D.C.: U.S. Department of Justice, February.

van Dyck, 1995, Age-related decline in striatal dopamine transporter binding with iodine-123-β-CITSPECT., J Nucl Med, 36, 1175

10.1523/JNEUROSCI.18-01-00419.1998

10.1002/ana.410360218

10.1016/0376-8716(79)90076-0

10.1016/0006-8993(80)91265-2

Wagner, 1980, Amphetamine induces caudate dopamine depletions in monkeys., Neurology, 30, 547, 10.1212/WNL.30.5.547

10.1016/0006-8993(83)90602-9

10.1038/nm0696-699

Wilson, 1996, Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson’s disease., Neurology, 47, 718, 10.1212/WNL.47.3.718

10.1002/syn.890150205

10.1016/0006-8993(89)91279-1

10.1002/mds.870100104